Restoring the quantity and quality of elderly human mesenchymal stem cells for autologous cell-based therapies

Medicine and Dentistry

• Mesenchymal Stem Cell 88%
• Stage Specific Embryo Antigen 4 23%
• Cell Therapy 17%
• Cells 17%
• Diseases 11%
• Aging 11%
• Cell Population 11%
• Phenotype 11%
• Galactosidase 11%
• Adenosine Triphosphate 11%
• Elderly Population 11%
• Fluorescence Activated Cell Sorting 11%
• Cell Surface Marker 11%
• Culture 11%
• Reactive Oxygen Species 11%
• Bone Marrow 11%
• Donor 11%
• Morphology 5%
• Degenerative Disease 5%
• Senescence 5%
• Infusion 5%
• Cell Proliferation 5%
• Biological Activity 5%
• Microenvironment 5%
• Extracellular Matrix 5%
• Plastic 5%
• Age 5%
• Bone Marrow Derived Mesenchymal Stem Cell 5%
• Assay 5%
• Tissues 5%
• Public Health 5%
• Ethinylestradiol Plus Megestrol Acetate 5%
• Stem Cell 5%
• Parent 5%
• Cell Size 5%
• Bone Marrow Cell 5%

Biochemistry, Genetics and Molecular Biology

• Stem Cell 100%
• Bone 23%
• Phenotype 11%
• Aging 11%
• Electric Potential 11%
• Galactosidase 11%
• Adenosine Triphosphate 11%
• Cell Surface Marker 11%
• Fluorescence Activated Cell Sorting 11%
• Species 11%
• Cell Proliferation 5%
• Morphology 5%
• Tissue Culture 5%
• CD90 5%
• Senescence 5%
• Biological Activity 5%
• Age 5%
• Health 5%
• Cell Size 5%